DUNN JOHN MICHAEL

Insider Buys Quantity –
3
2017-06-14PurchaseImmunic, Inc.
IMUX
General Counsel and Secretary
5,000
0.0118%
$3.09$15,449+75.81%
2015-10-26PurchaseImmunic, Inc.
IMUX
General Counsel and Secretary
4,000
0.0135%
$7.00$28,000+12.02%
2015-10-23PurchaseImmunic, Inc.
IMUX
General Counsel and Secretary
14,770
0.0509%
$6.76$99,866+18.34%
2009-02-19SaleBiogen Inc.
BIIB
EVP, New Ventures
3,208
0.0011%
$50.90$163,301-2.66%
2009-02-11SaleBiogen Inc.
BIIB
EVP, New Ventures
2,258
0.0008%
$50.81$114,729-3.19%
2008-07-22SaleBiogen Inc.
BIIB
EVP, New Ventures
6,485
0.0014%
$43.50$282,098-31.83%
2008-07-21SaleBiogen Inc.
BIIB
EVP, New Ventures
6,485
0.0014%
$43.50$282,098-27.26%
2008-04-14SaleBiogen Inc.
BIIB
EVP, New Ventures
3,212
0.0011%
$64.25$206,366-21.01%
2008-02-12SaleBiogen Inc.
BIIB
EVP, New Ventures
2,267
0.0008%
$61.14$138,597-12.9%
2007-07-25SaleBiogen Inc.
BIIB
EVP, New Ventures
20,000
0.0051%
$43.50$870,000+5.61%
2007-06-27SaleBiogen Inc.
BIIB
EVP, New Ventures
15,352
0.003%
$35.37$543,000+15.2%
2007-04-23SaleBiogen Inc.
BIIB
EVP, New Ventures
18,760
0.0055%
$48.90$917,364+22.78%
2007-04-20SaleBiogen Inc.
BIIB
EVP, New Ventures
7,519
0.0022%
$46.03$346,073+28.58%
2007-02-13SaleBiogen Inc.
BIIB
EVP, New Ventures
2,334
0.0007%
$49.22$114,870+15.8%
2006-11-15SaleBiogen Inc.
BIIB
EVP, New Ventures
7,850
0.0017%
$35.37$277,655+5.15%
2006-10-31SaleBiogen Inc.
BIIB
EVP, New Ventures
23,004
0.0067%
$46.77$1.08M+7.27%
2004-12-09SaleBiogen Inc.
BIIB
EVP, New Ventures
5,000
0.0008%
$35.37$176,850-40.29%
2004-11-08SaleBiogen Inc.
BIIB
EVP, New Ventures
571
0.0002%
$62.00$35,402-34.64%
2004-05-18SaleBiogen Inc.
BIIB
EVP, New Ventures
15,000
0.0044%
$59.05$885,800+0.76%